top
Search terms
Results 11 - 20 of 36 - ordered by :
Pages: 1 2 3 4
Ehjacc

Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A ...

European Heart Journal: Acute Cardiovascular Care, Original scientific paper, Evangelos Giannitsis, Lars Wallentin, Stefan K James, Maria Bertilsson, Agneta Siegbahn, Robert F Storey, Steen Husted, ...

Date : 04/04/2016 Item size : 84730 bytes
Ehjacc

Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A ...

European Heart Journal: Acute Cardiovascular Care, Original scientific paper, Evangelos Giannitsis, Lars Wallentin, Stefan K James, Maria Bertilsson, Agneta Siegbahn, Robert F Storey, Steen Husted, ...

Date : 04/04/2016 Item size : 84671 bytes
Ehjacc

Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A ...

European Heart Journal: Acute Cardiovascular Care, Original scientific paper, Evangelos Giannitsis, Lars Wallentin, Stefan K James, Maria Bertilsson, Agneta Siegbahn, Robert F Storey, Steen Husted, ...

Date : 04/04/2016 Item size : 84767 bytes
Ehjacc

Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A ...

European Heart Journal: Acute Cardiovascular Care, Original scientific paper, Evangelos Giannitsis, Lars Wallentin, Stefan K James, Maria Bertilsson, Agneta Siegbahn, Robert F Storey, Steen Husted, ...

Date : 04/04/2016 Item size : 84637 bytes
Ehjacc

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, Héctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016
Ehjacc

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, Héctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016
Ehjacc

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, Héctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016
Ehjacc

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, Héctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016
Ehjacc

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, Héctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016
Ehjacc

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, Héctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016